IEV (Ifosfamide, Epirubicin, VP16) Regimen as Salvage Therapy for Early Relapsed/Refractory non-Hodgkin/Hodgkin Lymphoma

IEV (Ifosfamide, Epirubicin, VP16) Regimen as Salvage Therapy for Early Relapsed/Refractory non-Hodgkin/Hodgkin Lymphoma

Show other versions (1)

Introduction: Management of early relapsed or refractory lymphoma [Hodgkin & non- Hodgkin Lymphoma (HL & NHL)] is a matter of problem, especially when hematopietic stem cell support is not available. The aim of this study was to evaluate effectiveness of IEV Regimen (Ifosfamide, Epirubicin,...

Full description

Bibliographic Details
Main Authors: Mohammadali Mashhadi, Hossein Rahimi, Behrooz Najafi, Adnan Khosravi
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2011-09-01
Series:International Journal of Hematology-Oncology and Stem Cell Research
Subjects:
IEV
Refractory NHL lymphoma
Salvage therapy
Hodgkin's lymphoma
Online Access:https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/281

Internet

https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/281

Similar Items